COPD
COPD and the pharmacist’s role
Chronic obstructive pulmonary disease (COPD) is a complex, chronic disease state that requires balancing lifestyle changes and multiple medications. Community pharmacists have an important role in counselling on medication adherence …
Research Roundup
Debbie Rigby takes a look at the latest in research news Management of type 2 diabetes in patients with frailty Newer antihyperglycemic agents such as glucagonlike peptide-1 receptor agonists (GLP1-RAs), …
Research Roundup
Debbie Rigby rounds up the latest in research news Cardiovascular risk assessment in women: which women are suited for menopausal hormone therapy? Individual risk assessment for atherosclerotic cardiovascular disease is …
Research Roundup
Debbie Rigby rounds up the latest in research news Risk of Fracture and Osteoporosis in Patients with COPD and Inhaled Corticosteroids Treatment This meta-analysis of 26 RCTs (n=61,380) concluded that …
Frailty and COPD
Frailty is common among people living with chronic obstructive pulmonary disease (COPD) and is associated with an increased risk of adverse patient outcomes. By Debbie Rigby, advanced practice pharmacist Learning …
Research Roundup
Debbie Rigby rounds up the latest in research news High use of short-acting beta-2-agonists in COPD is associated with an increased risk of exacerbations and mortality This observational study from …
Research Roundup
Debbie Rigby takes a look at the latest in research news Menopausal hormone therapy and dementia A case control study conducted with more than 60,000 women aged 50 to 60 …
Research Roundup
Debbie Rigby rounds up the latest in research news Evaluating the potential outcomes of pharmacist-led activities in the Australian general practice setting A prospective observational study was conducted in eight …
Research Roundup
Debbie Rigby rounds up the latest in research news Comparative Effectiveness of Umeclidinium/Vilanterol versus Inhaled Corticosteroid/Long-Acting β2-Agonist in Patients with Chronic Obstructive Pulmonary Disease Among patients with COPD without exacerbations …
COPD and CVD comorbidity
Optimal management of COPD should include identification and management of comorbidities. As COPD has a high rate of comorbidity with cardiovascular disease, patients with COPD may benefit from cardioprotective medications …
Research Roundup
Debbie Rigby rounds up the latest in research news Novel antihyperglycaemic drugs and prevention of chronic obstructive pulmonary disease exacerbations among patients with type 2 diabetes In this population based …
Research Roundup
Debbie Rigby takes a look at the latest in research news Beta-blocker therapy in patients with COPD Beta-blockers are associated with reduced mortality in patients with cardiovascular disease but are …